OTC:BRGX | Free Cash Flow | BIOREGENX, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$26,629.00
2025-12-31$69,636.00$3,057.00$66,579.00
2025-03-31$37,695.00$0.00$37,695.00
2024-12-31-$11,361.00$0.00-$11,361.00
2024-03-31-$104,250.00$189,390.00-$293,640.00
2023-12-31-$245,626.00$0.00-$245,626.00
2023-03-31-$566.00
2022-12-31-$4,364.00
2022-03-31-$20,920.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$38,972.00$9,057.00$29,915.00
2024-12-31-$324,148.00$189,390.00-$513,538.00
2023-12-31-$1.52M$0.00-$1.52M
2022-12-31-$64,652.00
2021-12-31-$119,517.00